Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Bharat Biotech in-licences GSK's Shigella vaccine candidate

Сообщение

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Войдите, чтобы отмечать, делиться и комментировать!

National

Israel and Iran exchange fresh strikes amid rising regional tensions

TEL AVIV: Israel and Iran engaged in a new round of attacks on each other overnight into Sunday,...

От 0 0

National

Widespread rain reported across Nepal, including Kathmandu

KATHMANDU: Rainfall is occurring in several parts of the country, including the Kathmandu Valley,...

От 0 1

National

Legislative Management Committee meeting taking place today

KATHMANDU: The Legislative Management Committee of the National Assembly is holding a meeting on...

От 0 9

Entertainment

Kartik's B'day wish for Sreeleela fuels romance buzz

Kartik Aaryan's playful birthday wish to Sreeleela, calling her "Monkey Face," has ignited...

От 0 15

National

Three workers killed in bailey bridge collapse in Panchthar

PANCHTHAR: Three workers injured in the collapse of an under-construction bailey bridge over the...

От 0 22